Independent · Beginner-Friendly · Data-Driven
46 articles found
India cuts 9 of every 10 diamonds on earth. A map of every export destination, and the one test that shows who really sets the price.
I sold, rebought ten minutes later, and booked nothing. Why a same day rebuy silently fails in India, and the FIFO quantity that decides your loss.
A layer-by-layer map of the companies supplying the AI power buildout, what their order books really say, and how to tell a franchise from a cycle.
AI data centers are not short of electricity. They are short of turbines, transformers and grid connections. A guide to the real energy bottleneck.
Advance tax has four deadlines a year and missing one costs 1% a month. A plain guide to the FY 2026-27 rules and how to avoid paying interest.
AI data centers need vastly more copper wiring and uranium-fueled power than ordinary infrastructure. A guide to the commodity side of the AI trade.
From AMD to Google's TPUs to Musk's Terafab and Huawei: a guide to every real challenge to Nvidia's AI chip dominance, and what's actually investable.
Nvidia can design more GPUs. What it cannot get more of is HBM memory and TSMC packaging capacity. Here is the real AI chip bottleneck, and why India has almost no exposure to it.
Is AI a threat to TCS, Infosys and Wipro, or their next growth engine? A data-driven guide to the billable-hours model under pressure.
AI data center economics explained: what a gigawatt really costs, why GPU depreciation beats the power bill, who profits, and is AI a bubble?
How Japan can now raise US dollars by pledging Treasuries instead of selling them, what changed this week, and what it means for bond yields.
Why most diversified portfolios are not diversified at all, how correlation actually works, and how to build a genuinely non-correlated portfolio.
How Japan's yen carry trade, Bank of Japan rate hikes and money coming home could shake global stocks, US bonds and your portfolio, explained.
A beginner-friendly breakdown of Mahesh Kaushik's ETF ki Dukan strategy, how to pick 75 liquid ETFs and trade them with one simple RSI rule.
ITC Q1 FY27 profit fell 16% on a cigarette tax hit, but FMCG-Others grew 21% and its profit share rose to 11%. A 5-year holder's read.
TCS Q1 FY27 earnings analysis: the US$2.6 billion AI revenue run-rate, why 13.9% rupee growth is only 3.2% in constant currency, and what to watch in FY27.
A business case study of Frido (Arcatron Mobility) and India's ergonomic-comfort D2C industry: the founder story, the direct-to-consumer model, the channel mix, and the competitive landscape.
How 20-year drug patents create billion-dollar moats, why Indian generics companies broke that system, and what patent cliffs mean for investors.
A plain-English guide to inflation and purchasing power, with worked examples in rupees and dollars and a step-by-step walkthrough of the Goal Planner tool.
The 12 metrics every investor must check before buying a pharma stock, explained simply with Indian examples from Sun Pharma, Cipla, and Dr. Reddy's.
A beginner-friendly, investor-first guide to biologics: what they are, how they're made in living cells, why they're so expensive and hard to copy, and why that matters for pharma investors.
How the bond market and stock market connect and move each other, the key data points to track, and 100 years of history, for beginners.
A deep dive into Mankind Pharma's business: how a Delhi-based company cracked Tier 2/3 India, built the Manforce and Gas-O-Fast brands, and what its premium valuation means for investors.
A beginner's guide to India's pharma value chain: from drug discovery to patient, every stakeholder, business, and investment opportunity explained.
Warning letters, import alerts, and consent decrees — a complete guide to US FDA enforcement actions against Indian pharma companies, with case studies on Ranbaxy, Sun Pharma, Cipla, Lupin and more.
A deep dive into Cipla's business: the 1935 founding, the HIV drug story that changed global pharma, its respiratory franchise, and honest bull and bear cases.
A deep dive into Dr. Reddy's business: how India's most export-focused pharma company built its US generics empire, its Russia franchise, and what the biosimilar bet means.
ITC's Q4 FY26 is not a clean quarter. A long-term shareholder breaks down the cigarette tax distortion, the FMCG inflection, and what to watch in FY27.
Holding IHCL since October 2020, here is my honest read of the Q4 and FY26 results, what impressed me and what I am watching closely going into FY27.
A long-term Dr. Reddy's investor breaks down Q4 FY26 earnings, what looks promising for FY27, and the concerns worth watching closely.
How Amit Nanwani and Diksha Pande grew Samosa Party from a Bengaluru side hustle into a 110-outlet, Rs 150 Cr Indian QSR brand across six cities.
How Kiran Shah left a P&G career to scale Apsara Ice Cream to 100 stores, then quit it all to build GoZero, India's leading sugar-free ice cream brand.
From nuclear plants to fiber cables: a beginner's guide to the 8-layer AI supply chain and the public companies in India and USA building each layer.
From Bihar's ponds to urban quick-commerce carts, how makhana became India's fastest-growing snack category and what it means for investors.
How TikTok, YouTube and Instagram turned a quiet $12B niche into a creator-driven growth machine, and what investors should know.
Google stock analysis: search dominance, AI transformation, competitive moats, and defending against ChatGPT - beginner investing guide.
NVIDIA stock analysis: gaming GPUs to AI dominance, CUDA moat, and investment thesis - semiconductor platform investing guide.
TCS stock analysis: IT services empire, competitive moats, AI transformation, and investment thesis - beginner guide to Indian tech stocks.
Deep dive into ITC's transformation from tobacco giant to diversified conglomerate - a beginner's guide to understanding multi-business models.
Stock valuation guide: P/E, PEG, DCF, margin of safety. Learn when to buy undervalued stocks using Warren Buffett's framework.
How to read annual reports like Warren Buffett: 20-minute framework for analyzing 10-K filings, financial statements, and finding moats.
Learn Warren Buffett's framework for competitive advantages. Discover the 7 types of economic moats with real-world examples from companies like Google, NVIDIA, and HDFC Bank.
Master P/E ratios, PEG, P/B, and EV/EBITDA with real examples from TCS, HDFC Bank, Google, and NVIDIA. Includes Indian market sector benchmarks.
Deep dive into HDFC Bank's history, products, competitive moat, and current business - a beginner's guide to understanding Indian banking.
Complete beginner's guide to the NIFTY 50 index: construction, top holdings, historical returns, vs SENSEX, and how to invest via index funds and ETFs.
Build your first diversified portfolio step-by-step. Indian tax implications, asset classes, behavioral traps, real portfolio examples using TCS, HDFC, ITC, and more.
